Virmani Sumeet, Harris Kathleen R, Szolc-Kowalska Barbara, Paunesku Tatjana, Woloschak Gayle E, Lee Fred T, Lewandowski Robert J, Sato Kent T, Ryu Robert K, Salem Riad, Larson Andrew C, Omary Reed A
Department of Radiology, Northwestern University, 737 N Michigan Ave, Ste 1600, Chicago, IL 60611, USA.
J Vasc Interv Radiol. 2008 Jun;19(6):931-6. doi: 10.1016/j.jvir.2008.02.019. Epub 2008 Apr 18.
To compare two methods to (a) propagate VX2 cell strain in rabbit hind limbs and (b) inoculate liver parenchymal tumors in rabbits.
One hundred forty-two New Zealand white rabbits were used for this study (60 with hind limb tumor [donors] and 82 with liver tumors [recipients]). In the donor group, nine rabbits received frozen VX2 cell suspension and 51 were injected with freshly prepared VX2 cell suspension. In the recipient group, 32 rabbits were injected with VX2 tumor cells and 50 were implanted with a small tumor fragment in the liver parenchyma. Success rates in terms of tumor growth were compared by using chi(2) or Fisher exact tests, with alpha = .05.
Hind limb and liver tumors were successfully grown in 48 of the 60 rabbits in the donor group (80%) and 57 of the 82 rabbits in the recipient group (70%). The success rate of growing hind limb tumors increased from 33% (three of nine rabbits) to 88% (45 of 51 rabbits) when fresh VX2 cells instead of frozen were injected percutaneously (P < .0011). Similarly, the success rate for VX2 liver tumors almost doubled from 47% (15 of 32 rabbits) to 84% (42 of 50 rabbits) when a tumor fragment instead of VX2 cell suspension was used (P < .00036). This also significantly reduced the frequency of metastasis (P < .005).
The authors recommend (a) the use of fresh VX2 cell suspension for percutaneous injection in the hind limbs of rabbits to maintain the VX2 cell strain and (b) the surgical implantation of freshly harvested VX2 tumor fragment into the liver parenchyma to establish liver tumors.
比较两种方法,一是在兔后肢繁殖VX2细胞株,二是在兔体内接种肝实质肿瘤。
本研究使用了142只新西兰白兔(60只患有后肢肿瘤[供体],82只患有肝肿瘤[受体])。在供体组中,9只兔接受冷冻VX2细胞悬液,51只注射新鲜制备的VX2细胞悬液。在受体组中,32只兔注射VX2肿瘤细胞,50只在肝实质内植入小肿瘤碎片。采用卡方检验或Fisher精确检验比较肿瘤生长的成功率,α = 0.05。
供体组60只兔中有48只(80%)成功长出后肢和肝脏肿瘤,受体组82只兔中有57只(70%)成功长出肿瘤。当经皮注射新鲜VX2细胞而非冷冻细胞时,后肢肿瘤生长成功率从33%(9只兔中的3只)提高到88%(51只兔中的45只)(P < 0.0011)。同样,当使用肿瘤碎片而非VX2细胞悬液时,VX2肝肿瘤的成功率几乎翻倍,从47%(32只兔中的15只)提高到84%(50只兔中的42只)(P < 0.00036)。这也显著降低了转移频率(P < 0.005)。
作者建议:(a)使用新鲜VX2细胞悬液经皮注射到兔后肢以维持VX2细胞株;(b)将新鲜采集的VX2肿瘤碎片手术植入肝实质以建立肝肿瘤。